Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
New Computational Methods for Improving Alzheimer’s Disease Characterization

New Computational Methods for Improving Alzheimer’s Disease Characterization

Review: Role of Alternative Splicing Defects in Major Neurodegenerative Diseases

Review: Role of Alternative Splicing Defects in Major Neurodegenerative Diseases

RNA Regulatory Mechanism Involving Stress Granules Directly Regulates Alzheimer’s Development

RNA Regulatory Mechanism Involving Stress Granules Directly Regulates Alzheimer’s Development

Game-Changing Research Shows Astrocytes as Key Regulators of Alzheimer's Disease Progression

Game-Changing Research Shows Astrocytes as Key Regulators of Alzheimer's Disease Progression

Researchers Elucidate the Molecular Mechanism of Protein Degradation by Extracellular Chaperones

Researchers Elucidate the Molecular Mechanism of Protein Degradation by Extracellular Chaperones

AI Used to Create 3D Model of 'Postal Workers' in Human Cells

AI Used to Create 3D Model of 'Postal Workers' in Human Cells

Discovering Novel Senolytic Compounds with the Power of Artificial Intelligence

Discovering Novel Senolytic Compounds with the Power of Artificial Intelligence

Remodeling in the Cell Membrane Alters Enzyme Activity Involved in Alzheimer’s

Remodeling in the Cell Membrane Alters Enzyme Activity Involved in Alzheimer’s

Abnormal Immune Activity in Astrocytes Causes Dementia-Related Cognitive Deficits

Abnormal Immune Activity in Astrocytes Causes Dementia-Related Cognitive Deficits

MIT Researchers Identify Brain Cells Most Susceptible to Neurodegeneration

MIT Researchers Identify Brain Cells Most Susceptible to Neurodegeneration

Brain Health Improved by Chemical Signals Released Through Exercise

Brain Health Improved by Chemical Signals Released Through Exercise

New Peptide Blocks a Hyperactive Brain Enzyme Involved in Neurodegeneration

New Peptide Blocks a Hyperactive Brain Enzyme Involved in Neurodegeneration

Astrocytes Pull the Handbrake to Drive the Brain to a More Relaxed State

Astrocytes Pull the Handbrake to Drive the Brain to a More Relaxed State

Using better probiotics to maintain a healthy gut microbiome

Using better probiotics to maintain a healthy gut microbiome

Study identifies 238 amyloid toxicity protective or activator genes

Study identifies 238 amyloid toxicity protective or activator genes

Delaying paralysis in ALS by using designer DNA drug

Delaying paralysis in ALS by using designer DNA drug

Scientists shed new light on aging processes in the brain

Scientists shed new light on aging processes in the brain

Study findings reveal drug development possibilities for brain diseases

Study findings reveal drug development possibilities for brain diseases

New signals of natural selection in humans identified

New signals of natural selection in humans identified

New technique may offer a pathway to treat undruggable diseases

New technique may offer a pathway to treat undruggable diseases

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.